|
2025
|
Invention
|
Muscle targeting complexes and uses thereof for treating dystrophinopathies.
Aspects of the disc... |
|
|
Invention
|
Complexes comprising an anti-transferrin receptor antibody linked to an oligonicleotide and metho... |
|
|
P/S
|
Providing medical and scientific research information in the field of pharmaceuticals; providing ... |
|
|
Invention
|
Muscle targeting complexes and uses thereof for treating muscular dystrophy.
Aspects of the disc... |
|
|
Invention
|
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy. ... |
|
|
Invention
|
Muscle targeting complexes and uses thereof for treating dystrophinopathies. Aspects of the discl... |
|
|
P/S
|
Pharmaceutical preparations for treating muscle diseases or disorders; pharmaceutical preparation... |
|
|
Invention
|
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and metho... |
|
|
Invention
|
Muscle targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonuc... |
|
|
Invention
|
Muscle-targeting complexes comprising an anti-transferin receptor antibody linked to an oligonucl... |
|
|
Invention
|
Methods and compositions for treating myotonic dystrophy. e.ge.ge.g., anti-TfRl antibody). |
|
2024
|
Invention
|
Muscle targeting complexes and formulations for treating facioscapulohumeral muscular dystrophy. ... |
|
|
P/S
|
Pharmaceutical preparations for treating muscle diseases or
disorders; pharmaceutical preparatio... |
|
|
Invention
|
Method of using an anti-transferrin receptor antibody to deliver an oligonucleotide to a subject ... |
|
|
Invention
|
Biomarkers for repeat expansion diseases. The present disclosure, in some aspects, provides one o... |
|
|
Invention
|
Muscle targeting complexes and formulations for treating dystrophinopathies.
Aspects of the disc... |
|
|
Invention
|
Muscle targeting complexes and uses thereof for treating myotonic dystrophy. Aspects of the discl... |
|
|
Invention
|
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide. Aspects ... |
|
|
Invention
|
Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonuc... |
|
|
P/S
|
Providing medical and scientific research information in the field of pharmaceuticals.
Providing ... |
|
|
P/S
|
Providing medical and scientific research information in the
field of pharmaceuticals. Providing... |
|
|
Invention
|
Methods and compositions for inhibiting progression of intramuscular fibrosis. The present applic... |
|
|
P/S
|
Pharmaceutical preparations for treating cardiac diseases or disorders; pharmaceutical preparatio... |
|
|
Invention
|
Muscle targeting complexes and formulations for treating myotonic dystrophy. Aspects of the discl... |
|
2023
|
Invention
|
Muscle targeting complexes and uses thereof for skipping exon 45 of a dmd gene. Aspects of the di... |
|
|
P/S
|
Providing medical and scientific research information in the field of pharmaceuticals Providing i... |
|
|
P/S
|
Research and development of pharmaceuticals for treating muscle diseases or disorders, cardiac di... |
|
|
Invention
|
Muscle targeting complexes and uses thereof for treating myotonic dystrophy.
Aspects of the disc... |
|
|
Invention
|
Dosing of muscle targeting complexes for treating myotonic dystrophy.
Aspects of the disclosure ... |
|
2022
|
Invention
|
Muscle targeting complexes for treating facioscapulohumeral muscular dystrophy.
Aspects of the d... |
|
|
Invention
|
Dosing of muscle targeting complexes for treating dystrophinopathies.
Aspects of the disclosure ... |
|
|
Invention
|
Muscle targeting complexes and uses thereof for treating myotonic dystrophy.
The present applica... |
|
|
Invention
|
Muscle targeting complexes and uses thereof for modulation of genes associated with muscle health... |
|
|
Invention
|
Muscle targeting complexes and uses thereof for treating friedreich's ataxia.
The present applic... |
|
|
Invention
|
Muscle targeting complexes and uses thereof for treating pompe disease.
Aspects of the disclosur... |
|
2021
|
Invention
|
Antibody-oligonucleotide complexes and uses thereof.
Provided herein are oligonucleotide-antibod... |
